Getting the (im) balance right: the involvement of Th17 cells in obesity

ARRUVITO LOURDES

Campos do Jordao

Congreso; XLI Congress of the Brazilian Society of Immunology.; 2016

Obesity induced inflammation is conducted by a metabolic pathway, which eventually causes activation of specialized immune cells and leads to an unresolved inflammatory response within the tissue. For this reason, it is critically important to determine how hypertrophic fat tissue alters T cell balance to drive inflammation. In the present study, we identify the purinergic signaling as a novel mechanism driving the adaptive Th17 response in human visceral adipose tissue (VAT) of metabolically unhealthy obese patients (MUO). We demonstrate that ATP acting via the P2X7 receptor pathway promotes a Th17 polarizing microenvironment with high levels of IL-1β, IL-6 and IL-17 in VAT explants from lean donors. Moreover, in vitro blockade of the P2X7 receptor abrogates the levels of these cytokines. These findings are consistent with a greater frequency of Th17 cells in tissue from MUO donors, revealed not only by the presence of a baseline Th17 promoting milieu, but also by the higher expression of steadily recognized Th17 markers as RORC, IL-17 cytokine and IL-23 receptor, in comparison with metabolically healthy obese and lean donors. Additionally, we demonstrate that CD39 expression on CD4+ effector T cells represents a novel Th17 marker in the inflamed VAT which also confers protection against ATP-induced cell death. The manipulation of the purinergic signaling might represent a new therapeutic target to shift the CD4+ T cell balance under inflammatory conditions